Allelic loss of the ING gene family loci is a frequent event in ameloblastoma

Oncology Research

Volumn 18, Issue 10, 2010, Pages 509-518

  Borkosky, Silvia S ^a   Gunduz, Mehmet ^a,b   Beder, Levent ^b   Tsujigiwa, Hidetsugu ^a   Tamamura, Ryo ^a   Gunduz, Esra ^a   Katase, Naoki ^a   Rodriguez, Andrea P ^a   Sasaki, Akira ^a   Nagai, Noriyuki ^a   Nagatsuka, Hitoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Allelic loss; Ameloblastoma; ING family; Microsatellite; Tumor suppressor genes

Indexed keywords

GENOMIC DNA; INHIBITOR OF GROWTH PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CHILD; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 2Q; CHROMOSOME 4Q; CHROMOSOME 7Q; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE LOCATION; GENE LOCUS; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INHIBITOR OF GROWTH GENE; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MULTIGENE FAMILY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SCHOOL CHILD; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

EID: 77954694838     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12704916124864     Document Type: Article

References (27)

1. Gardner, D. G.; Heikinheimo, K.; Shear, M.; Philipsen, H. P.; Coleman, H. Ameloblastomas. In: Barnes, L.; Evenson, J. W.; Reichart, P.; Sidransky, D., eds. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005:296-300.
2. Sciubba, J. J.; Fantasia, J. E.; Kahn, L. B. Benign odontopriate genic tumors. Atlas of tumor pathology. Tumor and cysts of the jaws. 1st ed. Washington, DC: Armed Forced Institute of Pathology; 2001.
3. Carlson, E. R.; Marx, R. E. The ameloblastoma: Primary, curative surgical management. J. Oral Maxillofac. Surg. 64:484-494; 2006.
4. Ghandhi, D.; Ayoub, A. F.; Pogrel, M. A.; MacDonald, G.; Brocklebank, L. M.; Moos, K. F. Ameloblastoma: A surgeon's dilemma. J. Oral Maxillofac. Surg. 64:1010-1014; 2006.
5. Hinds, P. W.; Weinberg, R. A. Tumor suppressor genes. Curr. Opin. Genet. Dev. 4:135-141; 1994.
6. Cowell, J. K. Tumour suppressor genes. Ann. Oncol. 3:693-698; 1992.
7. Gong, W.; Suzuki, K.; Russell, M.; Riabowol, K. Function of the ING family of PHD proteins in cancer. Int. J. Biochem. Cell Biol. 37:1054-1065; 2005.
8. Gunduz, M.; Gunduz, E.; Rivera, R. S.; Nagatsuka, H. The inhibitor of growth (ING) gene family: Potential role in cancer therapy. Curr. Cancer Drug Targets 8:275-284; 2008.
9. Kim, S.; Chin, K.; Gray, J. W.; Bishop, J. M. A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc. Natl. Acad. Sci. USA 101:16251-16256; 2004.
10. Okano, T.; Gemma, A.; Hosoya, Y.; Hosomi, Y.; Nara, M.; Kokubo, Y.; Yoshimura, A.; Shibuya, M.; Nagashima, M.; Harris, C. C.; Kudoh, S. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncol. Rep. 15:545-549; 2006.
11. Gunduz, M.; Ouchida, M.; Fukushima, K.; Hanafusa, H.; Etani, T.; Nishioka, S.; Nishizaki, K.; Shimizu, K. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 60:3143-3146; 2000. (Pubitemid 30407907)
12. Gunduz, M.; Ouchida, M.; Fukushima, K.; Ito, S.; Jitsumori, Y.; Nakashima, T.; Nagai, N.; Nishizaki, K.; Shimizu, K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21:4462-4470; 2002. (Pubitemid 34774848)
13. Gunduz, M.; Nagatsuka, H.; Demircan, K.; Gunduz, E.; Cengiz, B.; Ouchida, M.; Tsujigiwa, H.; Yamachika, E.; Fukushima, K.; Beder, L.; Hirohata, S.; Ninomiya, Y.; Nishizaki, K.; Shimizu, K.; Nagai, N. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356:109-117; 2005.
14. Cengiz, B.; Gunduz, M.; Nagatsuka, H.; Beder, L.; Gunduz, E.; Tamamura, R.; Mahmut, N.; Fukushima, K.; Al Sheikh Ali, M.; Naomoto, Y.; Shimizu, K.; Nagai, N. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol. 43:241-247; 2007. (Pubitemid 46228008)
15. Zhang, H. K.; Pan, K.; Wang, H.; Weng, D. S.; Song, H. F.; Zhou, J.; Huang, W.; Li, J. J.; Chen, M. S.; Xia, J. C. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett. 261:183-192; 2008.
16. Gunduz, M.; Beder, L. B.; Gunduz, E.; Nagatsuka, H.; Fukushima, K.; Pehlivan, D.; Cetin, E.; Yamanaka, N.; Nishizaki, K.; Shimizu, K.; Nagai, N. Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer. Cancer Sci. 99:531-538; 2008. (Pubitemid 351228570)
17. Borkosky, S. S.; Gunduz, M.; Nagatsuka, H.; Beder, L. B.; Gunduz, E.; Al Sheikh Ali, M.; Rodriguez, A. P.; Cilek, M. Z.; Tominaga, S.; Yamanaka, N.; Shimizu, K.; Nagai, N. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 135:703-713; 2009.
18. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90:10914-10921; 1993.
19. Nodit, L.; Barnes, L.; Childers, E.; Finkelstein, S.; Swalsky, P.; Hunt, J. Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod. Pathol. 17:1062-1067; 2004.
20. Migaldi, M.; Sartori, G.; Rossi, G.; Cittadini, A.; Sgambato, A. Tumor cell proliferation and microsatellite alterations in human ameloblastoma. Oral Oncol. 44:50-60; 2008. (Pubitemid 350251279)
21. Shibata, T.; Nakata, D.; Chiba, I.; Yamashita, T.; Abiko, Y.; Tada, M.; Moriuchi, T. Detection of TP53 mutation in ameloblastoma by the use of a yeast functional assay. J. Oral Pathol. Med. 31:534-538; 2002.
22. Kumamoto, H.; Izutsu, T.; Ohki, K.; Takahashi, N.; Ooya, K. p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas. J. Oral Pathol. Med. 33:292-299; 2004.
23. Levine, A. J.; Momand, J.; Finlay, C. A. The p53 tumour suppressor gene. Nature 351:453-456; 1991.
24. Honjo, N.; Gunduz, M.; Fukushima, K.; Cengiz, B.; Beder, L. B.; Gunduz, E.; Nagatsuka, H.; Xiao, J.; Shimizu, K.; Nishizaki, K. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms. Otolaryngol. Head Neck Surg. 137:119-125; 2007.
25. Boland, C. R.; Thibodeau, S. N.; Hamilton, S. R.; Sidransky, D.; Eshleman, J. R.; Burt, R. W.; Meltzer, S. J.; Rodriguez-Bigas, M. A.; Fodde, R.; Ranzani, G. N.; Srivastava, S. A National Cancer Institute workshop on microsatellite instability for cancer research detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248-5257; 1998.
26. Jääskeläinen, K.; Jee, K. J.; Leivo, I.; Saloniemi, I.; Knuutila, S.; Heikinheimo, K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet. Cytogenet. 136:31-37; 2002.
27. Toida, M.; Balázs, M.; Treszl, A.; Rákosy, Z.; Kato, K.; Yamazaki, Y.; Matsui, T.; Suwa, T.; Hatakeyama, D.; Makita, H.; Mori, S.; Yamashita, T.; Shibata, T.; Adány, R. Analysis of ameloblastomas by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet. Cytogenet. 159:99-104; 2005.